Andrew M. Haidle is a senior director at Blueprint Medicines (now a Sanofi company), where he works in drug discovery chemistry, applying expertise in complex molecule synthesis to the development of precision oncology and immunology therapeutics. Haidle earned his bachelor’s degree in chemistry from the University of Michigan.
EDUCATION
Graduate Studies
Harvard University
Chemistry
Graduate Thesis
Enantioselective Synthesis of (+)-L-696,474 and (+)-Cytochalasin B
Undergraduate Studies
University of Michigan
IMPACT STORY
Lorem ipsum dolor sit amet, consecteta aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.
READ MORE
GET IN TOUCH WITH Andrew Haidle
Lorem ipsum dolor sit amet, consecteta aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.ur adipiscing elit,
